FoxHollow Finds Rinspiration For Cardiac Market Entry Via Kerberos Purchase

FoxHollow's acquisition of the Rinspiration thrombectomy device through its $32 mil. purchase of Kerberos Proximal Solutions provides the firm with immediate access to the coronary market

More from Archive

More from Medtech Insight